Cargando…
Findings of (18)F‐PI‐2620 tau PET imaging in patients with Alzheimer’s disease and healthy controls in relation to the plasma P‐tau181 levels in a Japanese sample
BACKGROUND: Alzheimer’s disease (AD) is the most common cause of dementia worldwide. In AD, abnormal tau accumulates within neurons of the brain, facilitated by extracellular β‐amyloid deposition, leading to neurodegeneration, and eventually, cognitive impairment. As this process is thought to be ir...
Autores principales: | Bun, Shogyoku, Moriguchi, Sho, Tezuka, Toshiki, Sato, Yoshiaki, Takahata, Keisuke, Seki, Morinobu, Nakajima, Shinichiro, Yamamoto, Yasuharu, Sano, Yasunori, Suzuki, Natsumi, Morimoto, Ayaka, Ueda, Ryo, Tabuchi, Hajime, Ito, Daisuke, Mimura, Masaru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773651/ https://www.ncbi.nlm.nih.gov/pubmed/35843629 http://dx.doi.org/10.1002/npr2.12281 |
Ejemplares similares
-
Evaluation of [(18)F]PI-2620, a second-generation selective tau tracer, for assessing four-repeat tauopathies
por: Tezuka, Toshiki, et al.
Publicado: (2021) -
Case report: Non-Alzheimer's disease tauopathy with logopenic variant primary progressive aphasia diagnosed using amyloid and tau PET
por: Momota, Yuki, et al.
Publicado: (2022) -
Performance of plasma Aβ42/40, measured using a fully automated immunoassay, across a broad patient population in identifying amyloid status
por: Bun, Shogyoku, et al.
Publicado: (2023) -
Case Report: [(18)F]PI2620 as a Tau Imaging Agent in Posterior Cortical Atrophy
por: Kong, Yu, et al.
Publicado: (2020) -
Feasibility of short imaging protocols for [(18)F]PI-2620 tau-PET in progressive supranuclear palsy
por: Song, Mengmeng, et al.
Publicado: (2021)